CompletedPhase 4ACTRN12614000368639

A comparative clinical trial to study the effects of surgery combined with radiation therapy and surgery combined with 5- Fluorouracil in patients with ear Keloids

Comparison of efficacy of excision with intralesional 5- fluorouracil and excision with radiotherapy in the treatment of ear keloids: randomised control trial


Sponsor

Farrukh Aslam Khalid

Enrollment

120 participants

Start Date

May 17, 2014

Study Type

Interventional

Conditions

Summary

After approval from Ethical committee of our hospital, 120 patients presenting in the Department of Plastic Surgery through out patient department of Jinnah hospital, fulfilling the selection criteria will be included in the study. An informed consent will be obtained from them. Patients will be divided randomly in two groups by the help of random number table; Group A will be the patients of post excision radiotherapy and group B will be the patients post excision 5-FU. All the patients will be photographed and baseline assessment will be done before initiation of treatment by filling the proforma attached. All patients will undergo excision of the keloid under local anesthesia [2% lignocaine with 1:100,000 Adrenaline]. In group A, all patients will receive radiotherapy of total 10 Gy (2 fractions in two days) starting within 24 hours of excision. The target volume will be limited to the scar plus a 0.5-cm margin on both sides of suture lines. Ear lobe will be tapered away from the face and a direct anteroposterior field (with a small cone) will be used. In group B, excision followed by Intralesional 5-Fluorouracil [5-FU] injection in the dose of 50-150 mg divided between the excision margin and the wound bed. 5-FU will be given at two weekly interval. After giving local anesthesia [2% lignocaine +1:100,000 Adrenaline] using a 3cc syringe, 5-FU will be injected in the body of scar by using a 1cc syringe with premounted 27G needle, until slight blanching will be clinically visible. Assessment of patient will be done at 4, 8 weeks of treatment and 4 weeks after completion of treatment and then 6 monthly till 1 year for recurrance and mean scar reduction by the researcher.


Eligibility

Sex: Both males and femalesMin Age: 12 Yearss

Plain Language Summary

Simplified for easier understanding

This study is titled: A comparative clinical trial to study the effects of surgery combined with radiation therapy and surgery combined with 5- Fluorouracil in patients with ear Keloids. What is this study about? Researchers are conducting a clinical trial called "A comparative clinical trial to study the effects of surgery combined with radiation therapy and surgery combined with 5- Fluorouracil in patients with ear Keloids". The study aims to gather important medical data and evaluate outcomes in eligible participants. You may be eligible if: - You are at least 12 years old - Age above 12 years/either sex - Ear keloid more than 10mm in size measured clinically You may NOT be eligible if: - History of treatment taken in last 6 months - History of chronic renal failure or serum creatinine > 1.2mg/dl. - Abnormalities in liver function tests (ALT > 35 IU) and blood counts (WBC < 4 or > 11 thousand cells) on laboratory investigations. - Pregnant/lactating women or planning pregnancy Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

In group B (interventional group) patients will undergo excision of the keloid under local anesthesia [2% lignocaine + 1:100,000 Adrenaline] using 3cc syringe followed by Intralesional 5-Fluorouracil

In group B (interventional group) patients will undergo excision of the keloid under local anesthesia [2% lignocaine + 1:100,000 Adrenaline] using 3cc syringe followed by Intralesional 5-Fluorouracil [5-FU] injection with 1cc syringe and 27G needle average volumes to be 0.2 to 0.4 ml/cm2 in divided doses between the excision margin and the wound bed. With maximum dose not exceeding 150mg (50mg/ml injection). All patients will be seen at 7th day postoperatively for suture removal and then again at approximately 1 month and 2 months postoperatively for 5-FU injection. The dose of subsequent injection will be same. If there is no evidence of recurrence at the 2-month postoperative visit, the injections will be stopped. For those that showed hypertrophy either at completion of the second injection or on subsequent return, the injections will be continued at regular intervals in an attempt to arrest the inflammatory process. The injections will be stopped when the hypertrophy will worsen to the point of keloid formation or the hypertrophic process will subside with eventual flattening and resolution of the scar.


Locations(1)

Punjab, Pakistan

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12614000368639